Author:
Jenkins Christine R,Jones Paul W,Calverley Peter MA,Celli Bartolome,Anderson Julie A,Ferguson Gary T,Yates Julie C,Willits Lisa R,Vestbo Jörgen
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [ http://www.goldcopd.com ]
2. Calverley PM, Anderson JA, Celli B, Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007,356(8):775–789.
3. Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA, INSPIRE Investigators: The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008,177(1):19–26.
4. Zheng JP, Yang L, Wu YM, Chen P, Wen ZG, Huang WJ, Shi Y, Wang CZ, Huang SG, Sun TY, Wang GF, Xiong SD, Zhong NS: The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD. Chest 2007,132(6):1756–1763.
5. Calverley P, Pauwels RA, Jones PW, Anderson JA, Vestbo J: The severity of airways obstruction as a determinant of treatment response in COPD. Int J Chron Obstruct Pulmon Dis 2006,1(3):209–218.
Cited by
283 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献